Archive for March, 2016

Controversial “three-person embryos” should be approved for clinical trials in the U.S.

Author: Nicole Forgione, 03/31/16

Stem cell technology and reproductive medicine have always been tightly linked. After all, the early embryo is essentially a ball of stem cells. For this post, I will delve into a hot topic in reproductive medicine—three-person embryos. Similar to what we have seen with many cell therapies, this technology illustrates the potential of discoveries in…Read more

Right turn: Who said science and creativity had to be mutually exclusive?

Author: Erin Sugar, 03/25/16

Beautiful things can happen when you combine science, art and technology. (Think STEAM!) Contemporary dancer Paige Fraser has teamed up with Intel to create an artistic piece that uses 18 Intel RealSense cameras to display a whimsical 3D reflection that mimicks her real-life dancing. “The future’s bright when we figure out how to bring together…Read more

Update from the Clinic: February

Author: Mark Curtis, 03/24/16

Welcome to your Update from the Clinic for the month of February. bluebird made its debut in the oncology market and treated its first patient with a chimeric antigen receptor (CAR) product targeting a novel antigen. Ziopharm enrolled its first patient in a study investigating a non-viral CD19 CAR product, while Sangamo entered the clinic…Read more

Right Turn: Coming at you from a beach down south

Author: Stacey Johnson, 03/18/16

We don’t need no education We don’t need no thought control No dark sarcasm in the classroom Teachers leave them kids alone Hey! teachers! leave the kids alone! All in all it’s just another brick in the wall. All in all you’re just another brick in the wall. Pink Floyd’s “Another Brick in The Wall,”…Read more

Cell Therapy Deal Review: February

Author: Mark Curtis, 03/15/16

Welcome to your deal review for the month of February. Astellas tied-off its acquisition of Ocata while GSK and Adaptimmune expanded their collaboration to develop cell-based immunotherapies. AVROBIO, a new cell and gene company based in Boston, Mass, and Toronto, Ontario, launched with programs in leukemia in Fabry disease. After a drawn out process, Astellas…Read more

Right Turn: Hurray for tissue engineering!

Author: Stacey Johnson, 03/11/16

Tissue engineering is a key part of regenerative medicine (RM), but it sometimes feels like the poor cousin of stem cells. The Jan to big sister Marcia. That won’t be the case at the upcoming 10th World Biomaterials Congress (WBC2016), happening May 17-22 in Montreal, Quebec. It’s been 20 years since this event was held…Read more

What do car (and CAR) choices have to do with cell therapies?

Author: James Smith, 03/07/16

Post by James Smith and Mackenna Roberts. Ms. Roberts is an English-qualified lawyer, trained bioethicist and strategic adviser for the commercialization of emerging biomedical technologies and is widely published on how the law should govern cutting-edge medical therapies. She is an associate at IP Asset Partnership Ltd in London, IP consultant to IP Asset Ventures…Read more

Right Turn: Bio-hybrid device mimics kidney to remove need for dialysis

Author: Stacey Johnson, 03/04/16

Last week, I wrote about Dr. Leon Bellan’s creative solution to engineering artificial blood vessels for lab-grown organs: cotton candy! As much as I was impressed with his out-of-the-box thinking, I also really liked the excellent video produced by Vanderbilt University (VU), where Dr. Bellan runs his lab. So I went hunting for other VU…Read more